The table below shows CAPRICOR THERAPEUTICS, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$0.00
$22.27M
$25.18M
$2.55M
$244.90K
$310.25K
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$84.45M
$49.97M
$36.45M
$21.82M
$13.57M
$8.46M
SG&A
$23.69M
CAPR annual revenue (10-K history)
CAPRICOR THERAPEUTICS, INC. reported annual revenue of $0.00 for fiscal year 2025. That is down 100.0% from $22.27M in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $4.00M (FY 2016) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.